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Abstract
OBJECTIVE: To collect preliminary data on the ef-
fects of Saam acupuncture with regard to the im-
munity in cancer patients.
METHODS: Ten cancer patients were analyzed for
improvements in immunity. Acupuncture was ap-
plied at the 5 acupuncture points, Jingqu (LU 8), Zu-
tonggu (BL 66), Yanggu (SI 5), Yangchi (TE 4), and
Zhongwan (CV 12) for 2 weeks with 4 sessions. We
assessed the effect of Korean Saam acupuncture on
the immune system in cancer patients by measur-
ing particular blood cell subsets, including CD3+ ,
CD4+, CD8+, CD19+, and CD56+ cells, as well as to-
tal white blood cell count, absolute neutrophil
count, and fatigue score. The measurement was
performed before and after acupuncture and at a
2-week follow-up.
RESULTS: There was a statistically significant in-
crease in the number of CD3+ (P=0.023) and CD8+
cells (P<0.001) and T-cell subsets, as well as a de-
crease in the fatigue severity scale (FSS) score (P=
0.001) after Saam acupuncture using the 5 acu-
points.
CONCLUSION: Acupuncture may improve the im-
mune system by increasing the counts of a few im-
mune cells and relieve fatigue in cancer patients by
decreasing FSS scores. Although this was a
non-controlled study, it constitutes preliminary re-
search investigating the potential effects of Saam
acupuncture in increasing the counts of several im-
mune cells in cancer patients.
© 2014 JTCM. All rights reserved.
Key words: Acupuncture; Leukocyte count; Neutro-
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INTRODUCTION
Complementary and alternative therapies are mainly
adopted for balancing bodily functions, controlling ad-
verse effects, and enhancing the therapeutic effects of
conventional medicine.1 Acupuncture is also per-
formed in oncology clinics and has recently been used
for the improvement of immune function in cancer pa-
tients.2 Some studies have investigated whether acu-
puncture could improve immune function. A study re-
ported that acupuncture enhanced anticancer immune
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function by stimulating natural killer (NK) cells in ani-
mals and humans.3 Another study reported that T-lym-
phocyte subsets such as CD3 + , CD4 + , and CD8 +
cells, as well as NK cells, were substantially increased af-
ter acupuncture or moxibustion treatment in cancer pa-
tients.4 Furthermore, a single-armed study that in-
volved 28 cancer patients showed no decline in the ac-
tivity of CD3+ , CD4+ , CD8+ , or NK cells after 1
month of chemotherapy combined with electroacu-
puncture.5
T cells and NK cells play a role in defense against po-
tential tumors. These lymphocyte subsets express vari-
ous cell surface markers. Some T cells have CD3+ cell
surface markers, while NK cells have CD16 + and
CD56+ cell surface markers; moreover, T cells are fur-
ther classified as helper cells (CD4+) or cytotoxic cells
(CD8+).6 T helper (CD4+) and cytotoxic (CD8+) lym-
phocytes are directly involved in cell-mediated tumor
destruction, whereas NK cells are important in tumor
rejection.7 Thus, lymphocyte subset analyses can pro-
vide information regarding the immune status of a pa-
tient and help a physician monitor the therapeutic ef-
fects.
Fatigue is also a distressing symptom commonly experi-
enced by 80%-99% of cancer patients.8 Acupuncture
has been the focus of an increasing amount of research
in recent years. However, there seems to be a lack of
systematic research on acupuncture with regard to its
effects on fatigue. A recent study reported an improve-
ment in fatigue scores following acupuncture for chron-
ic post-chemotherapy fatigue.9,10
The efficacy of Korean Saam (or Sa-Ahm) acupuncture
has been rarely reported. Saam acupuncture is a unique
methodology within traditional Korean acupuncture
and is currently used by Korean clinicians. This study
investigated Saam acupuncture, which employs 4 acu-
points located on the upper or lower limbs and 1 acu-
point on the abdominal region. For a person who has
chronic exhaustion, this method is known to help re-
store vitality and balance the excess, as well as the defi-
ciency of the meridian.11,12
Our primary objectives were to collect preliminary da-
ta on the effects of Saam acupuncture with regard to
CD3+, CD4+, CD8+, CD19+, and CD56+ cells, as
well as white blood cell (WBC) counts, absolute neu-
trophil counts (ANCs), and the fatigue severity scale
(FSS) score,13 and determine whether the treatment of
Saam acupuncture may improve the immunity in can-
cer patients in terms of the counts of the cells mea-
sured. Our secondary goal was to verify the safety of
acupuncture in cancer patients.
MATERIALS ANDMETHODS
Study design
The institutional review board of Daegu Catholic Uni-
versity Hospital approved this research. We have ac-
quired informed consent from all patients. This study
was a prospective, single-arm, observational study. Par-
ticipants had 4 sessions of acupuncture administered
twice a week for 2 weeks. Improvement in the immune
cell numbers was evaluated via blood cell counts and
FSS score, as shown in Table 1. Participants were
screened based on the inclusion and exclusion criteria
described below. We confirmed the safety of the acu-
puncture by determining the red blood cell (RBC)
count, hemoglobin level, platelet count, mean corpus-
cular volume (MCV), mean corpuscular hemoglobin
(MCH), mean corpuscular hemoglobin concentration
(MCHC), hematocrit (Hct), aspartate aminotransfer-
ase (AST), alanine aminotransferase (ALT), creatinine
level, serum urea nitrogen (BUN), serum sodium level,
serum potassium level, and serum chloride level. All pa-
tients were evaluated 3 times, including a final fol-
low-up visit 4 weeks after the initiation of acupunc-
ture, at which time the levels of the CD3+ , CD4+ ,
CD8+, CD19+, and CD56+ cells, as well as the WBC
counts and ANCs, were determined, and the FSS
scores were assessed.
Patient recruitment and enrollment
Ten cancer patients participated in this study and were
screened from August 2012 to October 2012. The in-
clusion criteria were as follows: (a) Eastern Cooperative
Oncology Group (ECOG) performance score of ≤214
that corresponded to an ability to participate unassist-
ed or with occasional assistance in the trial; (b) age >40
years; (c) palliative operation and radio- or chemothera-
py occurred at least 2 months before trial initiation; (d)
a stable state despite having systemic or bone metasta-
ses; (e) consent to participate, and (f ) ability to attend
follow-up visits for the study duration.
The exclusion criteria were as follows: (a) a history of
sensitivity or allergy to acupuncture treatment; (b) seri-
Item
Time
Biochemical tests
Lymphocytes, WBC, and ANC
FSS values
Visit 1
Screening
1st week
√
-
-
Visit 2
Treatment
2nd and 3rd week
-
√
√
Visit 3
-
-
-
Visit 4
-
-
-
√
√
√
Visit 5 Visit 6
5th week
√
√
√
F/U evaluation
Notes: WBC: white blood cell; ANC: absolute neutrophil count; FSS: fatigue severity scale. √ mark means test was performed.
Table 1 Schedule of treatments and outcomemeasures throughout the trial
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ous medical or psychiatric conditions rendering partici-
pation in the trial unsuitable; (c) pharmacologic treat-
ment for the purpose of a clinical trial; (d) surgical op-
eration within 3 months before acupuncture treat-
ment, with the exception of monoclonal antibody or
hormone therapy; (e) a history of myocardial infarc-
tion or a cerebrovascular disease within 6 months be-
fore the trial, and (f) any communication problem.
Intervention
The study protocol involved 2 weeks of treatment with
2 acupuncture sessions per week. For all sessions, vital
signs including blood pressure, pulse rate, and body
temperature were measured before treatment. In all 4
sessions, acupuncture was applied for 20 min. Needle
stimulation was performed manually with a force
strong enough to generate a feeling of De Qi. A tradi-
tional Korean medicine physician who was registered
with the government and had practiced acupuncture
for more than 4 years performed the acupuncture. Acu-
puncture was applied at the 5 acupuncture points,
Jingqu (LU 8), Zutonggu (BL 66), Yanggu (SI 5),
Yangchi (TE 4), and Zhongwan (CV 12), by using ster-
ile, disposable, stainless steel needles (30 mm×0.25 mm;
Dongbang Acupuncture Inc., Chungcheongnam-do,
Korea). The skin was swabbed with an alcohol prep
pad prior to insertion of each needle, and the needles
were inserted 10-20 mm into the skin.
Saam acupuncture, which was used in this study, is a
method for supplementing the deficiency and draining
of excess meridian. Tonification and sedation of saam
acupuncture are achieved by two methods of needle
manipulation: one is to insert the needle with the direc-
tion (tonification) or against the direction (sedation) of
the meridian/channel course; the other is to rotate the
needle counterclockwise (sedation) or clockwise (tonifi-
cation). We applied a manual tonification: needles
were inserted along the channel and twisted 9 times
clockwise.12,15 For sedation, needles were inserted
against the channel and twisted 6 times counterclock-
wise. No electrical stimulation or other interventions
were used.
Statistical analysis
Statistical analyses were performed using SPSS version
19 (IBM Corp. Released 2010. IBM SPSS Statistics for
Windows, Version 19.0, Armonk, NY, USA). A P-val-
ue of <0.05 was considered statistically significant. Us-
ing quantitative data recorded over 6 follow up visits,
the mean FSS score and lymphocyte cell counts
(CD3+, CD4+, CD8+, CD19+, CD56+, WBC, and
ANC) were calculated for each participant. Changes be-
tween the initial time-point and the 2- and 4-week
time-points were evaluated using the Wilcoxon
signed-rank test for repeated measures, as well as
one-factor analysis.
RESULTS
Ten patients were included in the trial and completed a
total of 4 treatments and a follow-up session. A flow
chart of the trial participants is shown in Table 1. The
participants, including 5 men and 5 women, had a
mean age of 57.6 years (standard deviation, 10.69;
range, 41-75).
As shown in Table 2, the median CD3+ cell count was
661.830 cells/µL at baseline and rose to 819.000 cells/
µL at week 4, representing a statistically significant im-
provement (F=5.597; P=0.023). The median CD8 +
cell count was 298.670 cells/µL at baseline and was
404.830 cells/µL at week 4, representing a statistically
significant improvement (F=18.997; P<0.001). In the
Wilcoxon signed-rank test, there was a statistically sig-
nificant difference observed between week 4 and the
other measurements for acupuncture. However, the in-
tragroup analysis of the CD4+, CD19+, and CD56+
Table 2 Variations in the mean cell counts of the CD3+, CD4+, CD8+, CD19+, and CD56+ cells, as well as the WBC counts, ANCs,
and mean FSS score
Item
CD3+ (cells/µL)
CD4+ (cells/µL)
CD8+(cells/µL)
CD19+(cells/µL)
CD56+ (cells/µL)
WBC (1000× cells/µL)
ANC (1000× cells/µL)
FSS
Time, mean cell count (SD)
Visit 2
661.830 (263.965)
343.670 (193.975)
298.670 (155.152)
120.830 (53.252)
250.330 (207.228)
5.450 (1.896)
3.450 (1.683)
35.830 (11.720)
Visit 5
649.670 (270.128)
332.830 (170.856)
285.670 (181.070)
127.670 (51.481)
266.330 (216.655)
5.48 (1.839)
3.617 (1.938)
33.500 (10.483)
Visit 6
819.000 (376.635)
407.000 (251.352)
404.830 (161.392)
130.000 (52.108)
370.000(246.408)
4.850 (1.039)
2.850 (0.896)
19.500 (8.313)
F
(P value)
5.597 (0.023)a
3.644 (0.065)
18.997 (<0.001)a
0.291 (0.754)
2.805 (0.108)
0.691 (0.523)
0.901 (0.437)
14.591 (0.001)a
Notes: acupuncture was administered during visits 2-5. The lymphocyte counts, WBC counts, ANCs, and FSS scores were measured at
the 3 following time-points: pretreatment (Visit 2), posttreatment (Visit 5), and 2-week follow-up (Visit 6). WBC: white blood cell; ANC:
absolute neutrophil count; FSS: fatigue severity scale; SD: standard deviation. Data are expressed as mean cell count (SD). Statistically sig-
nificant differences (aP<0.05) were evaluated using a repeated measure one-factor analysis.
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cell counts showed no significant changes.
The median FSS score was 35.830 at baseline and
33.500 at week 2. The FSS score decreased to 19.5 at
week 4 (F=14.591; P=0.001) that was statistically dif-
ferent compared to that of the FSS scores at baseline
and week 2. All 10 enrolled patients showed a decrease
in the FSS score measured at baseline compared to
those of the follow-ups. The FSS scores between visit 2
and visit 6 decreased by 50%-150%, and FSS score be-
tween visit 5 and visit 6 decreased in the range of
56%-188%.
No adverse events were reported during the acupunc-
ture process.
DISCUSSION
In our study, the levels of T-lymphocyte subsets such as
CD3+ and CD8+ cells increased 2 weeks after the final
acupuncture treatment. In comparison with the base-
line levels, the mean CD3+ cell count at the 2-week fol-
low-up increased by 23.7% , and the CD8 + cells in-
creased by 35.5% . Our results were consistent with
those of other clinical trials that showed acupuncture
could result in a significant increase in lymphocyte
numbers. Furthermore, although not statistically signif-
icant, the mean values of the other cell subsets were al-
so increased at the 2-week follow-up and had similar
patterns to those of theCD3+ andCD8+ cells.
Regarding the response of the WBC count and ANC
to acupuncture, we found no statistically significant dif-
ferences between the baseline values and the 2-week fol-
low-up values, although the median WBC counts and
ANC per volume of blood reduced by 11.0% and
17.4% , respectively. However, several studies showed
that acupuncture increased the WBC counts or ANC
in cancer patients who were receiving chemothera-
py.20-22 In order to reconfirm the discrepancy between
our results and the other studies, we believe further
study is necessary with a larger number of participants,
including a comparison of an acupuncture group with
a control group.
In our study, acupuncture appeared to alleviate the can-
cer patients' fatigue. The FSS score had a mean im-
provement from baseline to follow up of 54.4%; more-
over, the FSS scores decreased from baseline to follow
up. In concurrence with our study, Vickers et al.9 re-
ported that 12 of 32 post-chemotherapy patients
(39% ) had improvements of 40% or more after acu-
puncture treatment, and 3 experienced 75% improve-
ments in their fatigue symptoms after acupuncture.
However, this study also had limitations, including the
absence of a control group. To objectively evaluate the
effects of acupuncture, we think comparison of a study
group to a control group is needed.
In this study, the decline of the immunity was induced
by yin deficiency with effulgent fire. Based on a charac-
teristics of Saam acupuncture of modulating imbalance
of excess and deficiency in body,15 we employed acu-
points to tonify water points and sedate fire points of
Five shu points located on the upper or lower limbs,
which consist of Jingqu (LU 8), Zutonggu (BL 66),
Yanggu (SI 5), and Yangchi (TE 4). Zhongwan (CV
12) in the extra channel was selected to modulate the
function of stomach. We hypothesized that the utiliza-
tion of these 5 acupoints could improve the immune
cell numbers of cancer patients, although a concrete
mechanism is not clear. In this study, the effect of acu-
puncture was evident during the final fourth week of
the trial. Additional follow up over a longer period
would help in verifying whether the effects of acupunc-
ture persist up to 4 weeks.
Despite the single-arm trial design, this pilot study sug-
gested that acupuncture might improve the CD3+ and
CD8+ cell counts and reduce fatigue in cancer patients
in Korea. For future study, we are planning large con-
trolled trials to confirm the efficacy of Saam acupunc-
ture for the improvement of immune cell numbers in
cancer patients.
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